Synapse - David Scheinberg

Results (445)

Parametric images of antibody pharmacokinetics in Bi213-HuM195 therapy of leukemia

Journal Article

Kolbert, K. S.; Hamacher, K. A.; Jurcic, J. G.; Scheinberg, D. A.; Larson, S. M.; Sgouros, G.
Journal of Nuclear Medicine (2001)

Fulltext@MSK | Save

Response of LNCaP spheroids after treatment with an α-particle emitter (213Bi)-labeled anti-prostate-specific membrane antigen antibody (J591)

Journal Article

Ballangrud, A. M.; Yang, W. H.; Charlton, D. E.; McDevitt, M. R.; Hamacher, K. A.; Panageas, K. S.; Ma, D.; Bander, N. H.; Scheinberg, D. A.; Sgouros, G.
Cancer Research (2001)

Fulltext@MSK | Save

Prognostic significance of minimal residual disease detection and PML/RAR-α isoform type: Long-term follow-up in acute promyelocytic leukemia

Journal Article

Jurcic, J. G.; Nimer, S. D.; Scheinberg, D. A.; Deblasio, T.; Warrell, R. P. Jr; Miller, W. H. Jr
Blood (2001)

Fulltext@MSK | Save

Breakthrough of 225Ac and its radionuclide daughters from an 225Ac/213Bi generator: Development of new methods, quantitative characterization, and implications for clinical use

Journal Article

Ma, D.; McDevitt, M. R.; Finn, R. D.; Scheinberg, D. A.
Applied Radiation and Isotopes (2001)

Fulltext@MSK | Save

Rapid preparation of short-lived alpha particle emitting radioimmunopharmaceuticals

Journal Article

Ma, D.; McDevitt, M. R.; Finn, R. D.; Scheinberg, D. A.
Applied Radiation and Isotopes (2001)

Fulltext@MSK | Save

Radioisotope conjugates

Book Section

Larson, S. M.; Divgi, C.; Sgouros, G.; Cheung, N. K. V.; Scheinberg, D. A.
In Rosenberg, S. A. (Eds.) Principles and Practice of the Biologic Therapy of Cancer. 3rd ed (2000)

Fulltext@MSK | Save

Relative efficacy of the alpha-particle emitters Bi-213 and Ac-225 for radioimmunotherapy against micrometastases: Dosimetric analysis and spheroid model response

Meeting Abstract

Ballangrud, A. M.; Yang, W. H.; Hamacher, K. A.; McDevitt, M. R.; Ma, D.; Scheinberg, D. A.; Sgouros, G.
Proceedings of the American Association for Cancer Research Annual Meeting (2000)

Fulltext@MSK | Save

Yttrium-90 anti-CD19 radioimmunotherapy for lymphoma

Meeting Abstract

Ma, D.; Barendswaard, E.; McDevitt, M. R.; Lai, L.; Curcio, M. J.; Pellegrini, V.; Brechbiel, M. W.; Scheinberg, D. A.
Cancer Biotherapy and Radiopharmaceuticals (2000)

Fulltext@MSK | Save

Phase I trial of yttrium-90-HuM195 (anti-CD33) in myeloid leukemia: Potential for myeloablation

Meeting Abstract

Jurcic, J. G.; Divgi, C. R.; McDevitt, M. R.; Ma, D.; Sgouros, G.; Hamacher, K. A.; Finn, R. D.; Larson, S. M.; Scheinberg, D. A.
Cancer Biotherapy and Radiopharmaceuticals (2000)

Fulltext@MSK | Save

Alpha particle emitter radioimmunotherapy of breast cancer micrometastases: Preclinical studies using MCF7 spheroids to assess response and microdosimetry following Hu3S193 (anti-le(y)) - Bi-213 treatment

Meeting Abstract

Ballangrud, A. M.; Yang, W. H.; Hamacher, K. A.; Charlton, D. E.; McDevitt, M. R.; Welt, S.; Scheinberg, D. A.; Sgouros, G.
Journal of Nuclear Medicine (2000)

Fulltext@MSK | Save